Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$12,848,088
+$496,535 QoQ
Shares Held
50,589
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#961
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $58,603,256 across 10 Drug Manufacturers - General names. JNJ ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,432 | $17,220,228 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
50,589 | $12,848,088 | |
| 3 | MRK |
Merck & Co., Inc.
|
98,070 | $12,601,995 | |
| 4 | LLY |
ELI LILLY & Co
|
5,314 | $6,373,771 | |
| 5 | AMGN |
Amgen Inc
|
8,505 | $3,079,830 | |
| 6 | PFE |
Pfizer Inc
|
120,987 | $2,913,366 | |
| 7 | NVS |
Novartis AG
|
13,967 | $2,188,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,810 | $607,695 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,848,088 | 50,589 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $12,351,553 | 50,530 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $10,317,285 | 49,854 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,243,928 | 49,854 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,686,838 | 50,323 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,545,901 | 51,531 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $7,453,136 | 51,536 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $8,489,026 | 52,382 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,576,057 | 51,834 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,476,217 | 47,261 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,929,946 | 50,593 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,321,099 | 53,426 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $11,783,037 | 71,188 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $10,792,185 | 69,627 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,455,913 | 59,190 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $9,950,420 | 60,911 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $10,871,067 | 61,242 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $10,036,180 | 56,628 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $9,570,682 | 55,946 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,023,812 | 55,875 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,046,202 | 54,912 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $8,477,008 | 51,579 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,892,614 | 43,796 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,236,434 | 41,889 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,843,879 | 41,555 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,309,453 | 40,490 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||